ELUCENIA / Sources and references
Sources and references · Page 6
Explore the literature and resources supporting ELUCENIA pages and tools, with links to the context in which each source appears.
Index of the documents, databases, methods and resources cited on the site. Each record shows where it is used. Inclusion does not imply an institutional partnership or endorsement of all source content.
4483 records
https://pubmed.ncbi.nlm.nih.gov/15793561/
https://pubmed.ncbi.nlm.nih.gov/15793561/Used in (1)
Myeloproliferative neoplasmshttps://doi.org/10.1093/ptj/67.2.206
https://doi.org/10.1093/ptj/67.2.206Used in (1)
Modified Ashworth Scale — Medical toolhttps://doi.org/10.1097/TA.0b013e3181c453b3
https://doi.org/10.1097/TA.0b013e3181c453b3Used in (1)
Revised Baux score — Medical toolSource for the active edition
https://pmc.ncbi.nlm.nih.gov/articles/PMC1746657/Used in (1)
CURB-65 — Medical toolhttps://www.cancer.gov/publications/dictionaries/cancer-terms/def/positive-predictive-value
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/positive-predictive-valueUsed in (1)
Positive predictive valueOPTN Policies effective October 1, 2026. Policy 9.1D: adult MELD score, dialysis definition and bounds.
https://www.hrsa.gov/sites/default/files/hrsa/optn/optn_policies.pdfUsed in (1)
MELD-Na and MELD 3.0 — Medical toolhttps://doi.org/10.1001/archinte.1916.00080130010002
https://doi.org/10.1001/archinte.1916.00080130010002https://doi.org/10.1034/j.1600-0625.2001.100102.x
https://doi.org/10.1034/j.1600-0625.2001.100102.xhttps://doi.org/10.1088/1674-1137/abddae
https://doi.org/10.1088/1674-1137/abddaeUsed in (1)
Radioactive decay — Medical toolhttps://doi.org/10.1001/jama.289.22.2983
https://doi.org/10.1001/jama.289.22.2983https://data.humantumoratlas.org/
https://data.humantumoratlas.org/https://doi.org/10.1016/S0140-6736(74)91770-X
https://doi.org/10.1016/S0140-6736(74)91770-XUsed in (1)
Forrest classification — Medical toolhttps://doi.org/10.1590/S0101-60832006000400004
https://doi.org/10.1590/S0101-60832006000400004European Society of Cardiology — diretrizes
https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/Registered source; no direct citation found in the pages of this edition.
https://doi.org/10.1055/s-0037-1616068
https://doi.org/10.1055/s-0037-1616068Used in (1)
ISTH overt DIC score — Medical toolhttps://pubmed.ncbi.nlm.nih.gov/7051819/
https://pubmed.ncbi.nlm.nih.gov/7051819/Used in (1)
Ranson’s criteria — Medical toolhttps://www.ncbi.nlm.nih.gov/geo/geo2r/
https://www.ncbi.nlm.nih.gov/geo/geo2r/Used in (1)
NCBI GEO2R · group comparison — Medical toolhttps://www.opencravat.org/
https://www.opencravat.org/https://doi.org/10.1164/ajrccm.166.1.at1102
https://doi.org/10.1164/ajrccm.166.1.at1102HOME. EASI guidance, internal header “EASI guidance December14”; official user guide, pages 1, 5 and 6.
https://www.homeforeczema.org/documents/easi-user-guide-dec-2016-v2.pdfBTS2023
https://www.brit-thoracic.org.uk/document-library/guidelines/pleural-disease/pleural-disease-full-supplement/Used in (1)
Light’s criteria — Medical toolhttps://doi.org/10.1164/rccm.201908-1581ST
https://doi.org/10.1164/rccm.201908-1581SThttps://doi.org/10.5712/rbmfc1(2)104
https://doi.org/10.5712/rbmfc1(2)104Source for the active edition
https://pubmed.ncbi.nlm.nih.gov/14553846/https://doi.org/10.1200/JCO.2011.39.9436
https://doi.org/10.1200/JCO.2011.39.9436https://doi.org/10.1016/j.ejca.2007.01.016
https://doi.org/10.1016/j.ejca.2007.01.016https://www.cancer.gov/publications/dictionaries/cancer-terms/def/minimal-residual-disease
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/minimal-residual-diseaseUsed in (1)
Minimal or measurable residual diseasehttps://doi.org/10.1111/j.1471-0528.1975.tb00710.x
https://doi.org/10.1111/j.1471-0528.1975.tb00710.xhttps://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq
https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdqUsed in (1)
MelanomaSource for the active edition
https://pubmed.ncbi.nlm.nih.gov/6720550/https://doi.org/10.1002/jhbp.515
https://doi.org/10.1002/jhbp.515https://www.ncbi.nlm.nih.gov/books/NBK545153/
https://www.ncbi.nlm.nih.gov/books/NBK545153/Used in (1)
Alveolar–arterial O₂ gradient — Medical toolSource for the active edition
https://pmc.ncbi.nlm.nih.gov/articles/PMC8822996/Source for the active edition
https://pubmed.ncbi.nlm.nih.gov/8594242/Used in (1)
Ottawa Knee Rule — Medical toolhttps://depmap.org/peddep/
https://depmap.org/peddep/https://doi.org/10.1542/peds.17.1.1
https://doi.org/10.1542/peds.17.1.1Used in (1)
Silverman–Andersen score — Medical toolhttps://doi.org/10.1503/cmaj.050051
https://doi.org/10.1503/cmaj.050051https://doi.org/10.1182/blood-2007-10-116327
https://doi.org/10.1182/blood-2007-10-116327Used in (1)
Khorana score — Medical toolhttps://doi.org/10.1378/chest.11-2297
https://doi.org/10.1378/chest.11-2297Used in (1)
Caprini score — Medical toolhttps://doi.org/10.1200/JCO.19.01461
https://doi.org/10.1200/JCO.19.01461Used in (1)
Khorana score — Medical toolNHMRC — diretrizes
https://www.nhmrc.gov.au/guidelinesRegistered source; no direct citation found in the pages of this edition.
https://doi.org/10.1002/hep.21496
https://doi.org/10.1002/hep.21496Used in (1)
NAFLD Fibrosis Score (NFS) — Medical toolhttps://doi.org/10.1001/jama.2016.0287
https://doi.org/10.1001/jama.2016.0287Source for the active edition
https://pubmed.ncbi.nlm.nih.gov/20038856/Used in (1)
Revised Baux score — Medical toolhttps://www.cancer.gov/types/bladder/hp/bladder-treatment-pdq
https://www.cancer.gov/types/bladder/hp/bladder-treatment-pdqUsed in (1)
Bladder cancerhttps://doi.org/10.1161/01.CIR.75.3.565
https://doi.org/10.1161/01.CIR.75.3.565Used in (1)
ECG voltage criteria for LVH — Medical toolhttps://www.cvdrisk.com.cn/ASCVD/Eval
https://www.cvdrisk.com.cn/ASCVD/EvalUsed in (1)
Fuwai · China-PAR — Medical toolhttps://doi.org/10.1038/ajg.2009.28
https://doi.org/10.1038/ajg.2009.28Used in (1)
BISAP score — Medical toolhttps://www.cancer.gov/types/prostate
https://www.cancer.gov/types/prostateUsed in (1)
Prostate cancerhttps://doi.org/10.1183/13993003.02730-2021
https://doi.org/10.1183/13993003.02730-2021Used in (1)
Asthma symptom control (GINA) — Medical toolhttps://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq
https://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdqUsed in (1)
Brain and central nervous system tumorshttps://doi.org/10.1002/ajpa.1330100407
https://doi.org/10.1002/ajpa.1330100407https://www.cancer.gov/pediatric-adult-rare-tumor/
https://www.cancer.gov/pediatric-adult-rare-tumor/Used in (1)
Rare cancershttps://doi.org/10.1016/j.cell.2017.10.014
https://doi.org/10.1016/j.cell.2017.10.014Used in (1)
Soft tissue sarcomashttps://www.aacap.org/App_Themes/AACAP/docs/member_resources/toolbox_for_clinical_practice_and_outcomes/symptoms/NICHQ_Vanderbilt_Assessment_Follow_Up-PARENT-Informant.pdf
https://www.aacap.org/App_Themes/AACAP/docs/member_resources/toolbox_for_clinical_practice_and_outcomes/symptoms/NICHQ_Vanderbilt_Assessment_Follow_Up-PARENT-Informant.pdfhttps://doi.org/10.1385/fsmp:3:1:33
https://doi.org/10.1385/fsmp:3:1:33https://doi.org/10.1016/j.echo.2017.02.009
https://doi.org/10.1016/j.echo.2017.02.009https://doi.org/10.1542/peds.19.5.823
https://doi.org/10.1542/peds.19.5.823https://doi.org/10.1016/0952-8180(94)00001-K
https://doi.org/10.1016/0952-8180(94)00001-KUsed in (1)
Modified Aldrete score — Medical toolAmerican Heart Association / ASA — diretrizes e declarações
https://professional.heart.org/en/guidelines-and-statementsRegistered source; no direct citation found in the pages of this edition.
https://doi.org/10.1249/MSS.0b013e318213fefb
https://doi.org/10.1249/MSS.0b013e318213fefbhttps://www.riskofbias.info/welcome/rob-2-0-tool
https://www.riskofbias.info/welcome/rob-2-0-toolhttps://www.cancer.gov/types/skin
https://www.cancer.gov/types/skinhttps://www.nimh.nih.gov/sites/default/files/documents/research/research-conducted-at-nimh/asq-toolkit-materials/asq-tool/summary-sheet-asq-nimh-toolkit.pdf
https://www.nimh.nih.gov/sites/default/files/documents/research/research-conducted-at-nimh/asq-toolkit-materials/asq-tool/summary-sheet-asq-nimh-toolkit.pdfhttps://www.eviq.org.au/clinical-resources/eviq-calculators/4171-carboplatin-dose-calculator
https://www.eviq.org.au/clinical-resources/eviq-calculators/4171-carboplatin-dose-calculatorUsed in (1)
Carboplatin dose (Calvert) — Medical toolhttps://iciq.net/iciq-ui-sf
https://iciq.net/iciq-ui-sfAHA scientific statement2019,Measurement of Blood Pressure in Humans
https://pmc.ncbi.nlm.nih.gov/articles/PMC11409525/Andersson M, Andersson RE. Erratum to: The Appendicitis Inflammatory Response Score: A Tool for the Diagnosis of Acute Appendicitis that Outperforms the Alvarado Score. World J Surg, 2012;36:2269–2270. Corrected Tables 2 and 7.
https://doi.org/10.1007/s00268-012-1679-9Source for the active edition
https://pmc.ncbi.nlm.nih.gov/articles/PMC1383057/Used in (1)
Rockall score — Medical toolhttps://pubmed.ncbi.nlm.nih.gov/25563062/
https://pubmed.ncbi.nlm.nih.gov/25563062/https://doi.org/10.1056/NEJM199701233360402
https://doi.org/10.1056/NEJM199701233360402https://doi.org/10.1097/ALN.0b013e3181fc6e0a
https://doi.org/10.1097/ALN.0b013e3181fc6e0aUsed in (1)
ARISCAT — Medical toolSource for the active edition
https://pubmed.ncbi.nlm.nih.gov/22797452/https://mini-cog.com/download-the-mini-cog-instrument/
https://mini-cog.com/download-the-mini-cog-instrument/https://doi.org/10.1161/CIR.0000000000000923
https://doi.org/10.1161/CIR.0000000000000923https://doi.org/10.1111/j.1365-2133.2005.06502.x
https://doi.org/10.1111/j.1365-2133.2005.06502.xhttps://www.pennstatehealth.org/childrens/newborn-weight-tool
https://www.pennstatehealth.org/childrens/newborn-weight-toolUsed in (1)
NEWT · newborn weight tool — Medical toolSource for the active edition
https://pubmed.ncbi.nlm.nih.gov/7165009/Used in (1)
ECOG and Karnofsky — Medical toolhttps://pmc.ncbi.nlm.nih.gov/articles/PMC3291956/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3291956/Used in (1)
Boston University · AM-PAC — Medical toolNo results for this search.